PMID: 6540189Jul 1, 1984Paper

Bone scintigraphy in patients with operable breast cancer stages I and II. Final conclusion after five-year follow-up

European Journal of Cancer & Clinical Oncology
R M ButzelaarJ B van der Schoot

Abstract

A 5-yr follow-up study was performed in 90 patients with stage I and II breast cancer who had a routine preoperative bone scan. The percentage of positive preoperative scans was 3.4%. Twenty-four of the 90 patients died within 5 yr. In all patients except five a follow-up scan was obtained. The results of our first study were confirmed. In only one of the three patients with a positive preoperative scan suspicious for bone metastases did bone metastases develop in this 5-yr follow-up study. One patient with an equivocal preoperative scan developed bone metastases. In 14 of the 16 patients with bone metastases and a positive scan in the follow-up period the preoperative scan was negative. From the preoperative and follow-up scan results we conclude that in stage I and II breast cancer there is no value in preoperative bone scanning. Routine bone scanning in the follow-up period appears to have little value in the asymptomatic patient.

References

Aug 11, 1977·The New England Journal of Medicine·F H GerberW J Fouty
Apr 1, 1980·Archives of Surgery·G S WilsonM J Brennan

❮ Previous
Next ❯

Citations

Jan 1, 1990·Journal of Cancer Research and Clinical Oncology·H SchünemannH Merkl
Jun 1, 1987·European Journal of Cancer & Clinical Oncology·H S ThomsenK W Andersen
Feb 28, 1998·The Orthopedic Clinics of North America·K J Donohoe
Mar 1, 1991·Clinical Oncology : a Journal of the Royal College of Radiologists·H KennedyM Horobin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.